BackElicio Therapeutics Overview

Elicio Therapeutics Long Term Debt

Elicio Therapeutics's long-term debt is $3.5M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$3.54M
↓ 74.62% YoYΔ $-10.41M vs prior year quarter

Peer trimmed avg / median

Loading

Elicio Therapeutics Long Term Debt History

Loading

Elicio Therapeutics vs. peers: Long Term Debt Comparison

Loading

Elicio Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Elicio Therapeutics (ELTX) FAQ

Elicio Therapeutics (ELTX) currently reports a long-term debt of $3.5M as of June 2026. That compares with $14M in the prior-year period — down 74.6% year over year. Use the charts on this page to explore Elicio Therapeutics's long-term debt history and peer comparisons.

Elicio Therapeutics's long-term debt decreased from $14M to $3.5M — a 74.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Elicio Therapeutics reported $3.5M in long-term debt as of June 2026. That compares with $14M in the prior-year period — down 74.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $3.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Elicio Therapeutics, and consider following ELTX for alerts when major investors trade the stock.